β-cell telomere attrition in diabetes: Inverse correlation between HbA1c and telomere length

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages 2771-2777

  Tamura, Yoshiaki ^a   Izumiyama Shimomura, Naotaka ^a   Kimbara, Yoshiyuki ^a   Nakamura, Ken Ichi ^a   Ishikawa, Naoshi ^a   Aida, Junko ^a   Chiba, Yuko ^a   Mori, Seijiro ^a   Arai, Tomio ^a   Aizawa, Toru ^b   Araki, Atsushi ^a   Takubo, Kaiyo ^a   Ito, Hideki ^a  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

^b Aizawa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INSULIN-SECRETING CELLS; MALE; TELOMERE; TELOMERE SHORTENING;

EID: 84905851692     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1222     Document Type: Article

References (39)

1. van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17(suppl 1):S3-S8.
2. Tataranni PA, Bogardus C. Metabolic abnormalities in the development of type 2 diabetes mellitus. In: LeRoith D, Olefsky JM, Taylor SI, eds. Diabetes Mellitus: A Fundamental and Clinical Text. 3rd ed. Philadelphia: Lippincott Williams, Wilkins; 2004:797-807.
3. Alsahli M, Gerich JE. Abnormalities of insulin secretion and β-cell defects in type 2 diabetes. In: Holt RIG, Cockram C, Flyvbjerg A, Goldstein BJ, eds. Textbook of Diabetes. 4th ed. Chichester, UK: Wiley-Blackwell; 2010:160-173.
4. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-110.
5. Maedler K, SchumannDM, Schulthess F, et al. Aging correlates with decreased β-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. Diabetes. 2006;55:2455-2462.
6. Reers C, Erbel S, Esposito I, et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol. 2009;160:185-191.
7. Gunasekaran U, Gannon M. Type 2 diabetes and the aging pancreatic β - cell. Aging (Albany NY). 2011;3:565-575.
8. Kushner JA. The role of aging upon β - cell turnover. J Clin Invest. 2013;123:990-995.
9. Blackburn EH. Switching and signaling at the telomere. Cell. 2001; 106:661-673.
10. Blackburn EH. Structure and function of telomeres. Nature. 1991; 350:569-573.
11. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990;346:866-868.
12. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585-621.
13. Jeanclos E, Krolewski A, Skurnick J, et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes. 1998;47:482-486.
14. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care. 2006;29:283-289.
15. Tentolouris N, Nzietchueng R, Cattan V, et al. White blood cell telomere length is shorter in males with type 2 diabetes and microalbuminuria. Diabetes Care. 2007;30:2909-2915.
16. Testa R, Olivieri F, Sirolla C, et al. Leukocyte telomere length is associated with complications of type 2 diabetes mellitus. Diabet Med. 2011;28:1388-1394.
17. Olivieri F, Lorenzi M, Antonicelli R. Leukocyte telomere shortening in elderly type 2 DM patients with previous myocardial infarction. Atherosclerosis. 2009;206:588-593.
18. Astrup AS, Tarnow L, Jorsal A, et al. Telomere length predicts allcause mortality in patients with type 1 diabetes. Diabetologia. 2010; 53:45-48.
19. Kuhlow D, Florian S, von Figura G, et al. Telomerase deficiency impairs glucose metabolism and insulin secretion. Aging (Albany NY). 2010;2:650-658.
20. Guo N, Parry EM, Li LS, et al. Short telomeres compromise β-cell signaling and survival. PLoS One. 2011;6:e17858.
21. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan.AmJ Kidney Dis. 2009; 53:982-992.
22. Takubo K, Fujita M, Izumiyama N, et al. Q-FISH analysis of telomere and chromosome instability in the oesophagus with and without squamous cell carcinoma in situ. J Pathol. 2010;221:201-209.
23. Aida J, Izumiyama-Shimomura N, Nakamura K, et al. Basal cells have longest telomeres measured by tissue Q-FISH method in lingual epithelium. Exp Gerontol. 2008;43:833-839.
24. Aida J, Izumo T, Shimomura N, et al. Telomere lengths in the oral epithelia with and without carcinoma. Eur J Cancer. 2010;46:430-438.
25. Bonner-Weir S, Deery D, Leahy JL, WeirGC.Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes. 1989;38:49-53.
26. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced β-cell mass and expression of oxidative stressrelatedDNAdamage in the islet of Japanese type II diabetic patients. Diabetologia. 2002;45:85-96.
27. Matsui-Hirai H, Hayashi T, Yamamoto S, et al. Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide. J Pharmacol Exp Ther. 2011;337:591-599.
28. Kobayashi M, Yamazaki K, Hirao K, et al. Japan Diabetes Clinical Data Management Study Group. The status of diabetes control and antidiabetic drug therapy in Japan-a cross-sectional survey of 17 000 patients with diabetes mellitus (JDDM 1). Diabetes Res Clin Pract. 2006;73:198-204.
29. Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY. Sulfonylurea induced β-cell apoptosis in cultured human islets. J Clin Endocrinol Metab. 2005;90:501-506.
30. Sawada F, Inoguchi T, Tsubouchi H, et al. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic β-cell line, MIN6. Metabolism. 2008;57: 1038-1045.
31. Zhao J, Zhu Y, Lin J, et al. Short leukocyte telomere length predicts risk of diabetes in American Indians: the strong heart family study. Diabetes. 2014;63:354-362.
32. van der Harst P, Wong LS, de Boer RA, et al. MERIT-HF Study Group. Possible association between telomere length and renal dysfunction in patients with chronic heart failure. Am J Cardiol. 2008; 102:207-210.
33. Wong LS, van der Harst P, de Boer RA, et al. Renal dysfunction is associated with shorter telomere length in heart failure. Clin Res Cardiol. 2009;98:629-634.
34. Takubo K, Aida J, Izumiyama N, et al. Chromosomal instability and telomere lengths of each chromosomal arm measured by Q-FISH in human fibroblast strains prior to replicative senescence. Mech Ageing Dev. 2010;131:614-624.
35. Günes C, Rudolph KL. The role of telomeres in stem cells and cancer. Cell. 2013;152:390-393.
36. Nakamura K, Takubo K, Izumiyama-Shimomura N, et al. Telomeric DNA length in cerebral gray and white matter is associated with longevity in individuals aged 70 years or older. Exp Gerontol. 2007;42:944-950.
37. Ishikawa N, Nakamura K, Izumiyama N, et al. Telomere length dynamics in the human pituitary gland: robust preservation throughout adult life to centenarian age. Age (Dordr). 2012;34: 795-804.
38. Takubo K, Izumiyama-Shimomura N, Honma N, et al. Telomere lengths are characteristic in each human individual. Exp Gerontol. 2002;37:523-531.
39. Ishii A, Nakamura K, Kishimoto H, et al. Telomere shortening with aging in the human pancreas. Exp Gerontol. 2006;41:882-886.